<noscript id="qeqk6"></noscript>
<noscript id="qeqk6"></noscript>
<center id="qeqk6"></center>
<optgroup id="qeqk6"></optgroup>
<optgroup id="qeqk6"><div id="qeqk6"></div></optgroup><center id="qeqk6"><wbr id="qeqk6"></wbr></center>

AIM Rule 26

The information contained within the section of this website is for the purposes of AIM Rule 26:

Business Description

Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.

Our mission is to serve life scientists to help them achieve their mission faster by listening to their needs, continuously innovating and improving and by giving them the tools, data and experience they want. Our ambition is to become the most influential life science company for researchers worldwide.

The company was founded in 1998 and has been listed on the AIM market of the London Stock Exchange since 2005.

To find out more.

Company Directors

Information on the Company Directors can be found here.

Corporate Governance

Information on Corporate Governance can be found here.

UK Takeover Code Applicability

The UK City Code on Takeovers and Mergers applies to the Company.

Country of Incorporation and Operations

Country of incorporation : England and Wales
Company registration number : 3509322
Main country of operation : United Kingdom

Company Documents

Articles of Association
Admission Document
Memorandum of Association

Annual Reports?and Accounts

Annual Reports and Accounts for the last three years can be found here.

Details of Restrictions on the Transfer of Securities

There are no restrictions on the transfer of ordinary shares.

Details of any other Exchanges

The securities of the Company are traded on the AIM market operated by the London Stock Exchange plc. Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.

Securities Information

AIM securities in issue: As at 30 April 2019 there were 205,597,614 ordinary shares of 0.2 pence each.
As at 30 April 2019 the percentage of shares not held in public hands (as defined by AIM rule 26) was 23.05%.
The identity and shareholdings of the Company’s significant shareholders can be found here.

Advisor Information

All Company Advisor Information can be found here.

Registered Address

Regulatory News

This information was last updated on 31 October 2017.

About Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.

Read more +

Abcam Products

As an innovator in reagents and tools, Abcam offers highly validated binders and assays to address important targets in critical biological pathways.

Read more +

Investor Information

Abcam is listed on the AIM market of the London Stock Exchange under the ticker ABC, and our investors' centre includes a range of information on our company, including our news, financial reports and investor contacts

Read more +

Abcam News

We provide updates on our commercial and financial progress through regular press releases which can be accessed through the Company's media centre.

Read more +